Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC

被引:15
|
作者
Roncari, B.
Pedroni, M.
Maffei, S.
Di Gregorio, C.
Ponti, G.
Scarselli, A.
Losi, L.
Benatti, P.
Roncucci, L.
De Gaetani, C.
Camellini, L.
Lucci-Cordisco, E.
Tricarico, R.
Genuardi, M.
de Leon, M. Ponz
机构
[1] Univ Modena & Reggio Emilia, Dept Med & Med Specialities, I-41100 Modena, Italy
[2] Civil Hosp Carpi, Pathol Unit, Modena, Italy
[3] Univ Modena & Reggio Emilia, Dept Pathol, Modena, Italy
[4] Santa Maria Nuova Hosp, Gastrointestinal Endoscopy Unit, Reggio Emilia, Italy
[5] Catholic Univ A Germelli Sch Med, Inst Med Genet, Rome, Italy
[6] Univ Florence, Sch Med, Dept Clin Pathophysiol, Med Genet Sect, Florence, Italy
关键词
colorectal cancer; HNPCC; immunohistochemistry; MSH6; MSI;
D O I
10.1111/j.1399-0004.2007.00856.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A large majority of constitutional mutations in hereditary non-polyposis colorectal cancer (HNPCC) are because of the MHL1 or MSH2 genes. In a lower fraction of cases, another gene of the mismatch repair (MMR) machinery, MSH6, may be responsible. Families with MSH6 mutations are difficult to recognize, as microsatellite instability (MSI) may not be detectable and immunohistochemistry (IHC) may give ambiguous results. In the present study, we proposed (i) to determine the frequency of MSH6 mutations in a selected population of colorectal cancer patients obtained from a tumor registry, (ii) to assess whether IHC is a suitable tool for selecting and identifying MSH6 mutation carriers. One hundred neoplasms of the large bowel from suspected HNPCC families were analyzed for MSI (BAT25 and BAT26 markers) and immunohistochemical expression of the MSH6 protein. We found on 12 tumors (from different families) showing instability or lack of MSH6 expression. Among these, four potentially pathogenic MSH6 mutations were detected (del A at 2984; del TT at 3119; del AGG cod 385; and del CGT cod 1242) by direct gene sequencing. These represented 12.9% of all families with constitutional mutations of the DNA MMR genes. Thus, some 5% of all HNPCC families are featured by constitutional mutation of the MSH6 gene. This appears, however, as a minimum estimate; routine use of IHC and the study of large numbers of individuals and families with little or no evidence of Lynch syndrome might reveal that mutation of this gene account for a large fraction of HNPCC.
引用
收藏
页码:230 / 237
页数:8
相关论文
共 50 条
  • [21] Novel dominant mutations in Saccharomyces cerevisiae MSH6
    Das Gupta, R
    Kolodner, RD
    NATURE GENETICS, 2000, 24 (01) : 53 - 56
  • [22] High Frequency of MSH6 Germline Mutations in Early-Onset Colorectal Cancer
    Giraldez, Maria Dolores
    Balaguer, Francesc
    Cuatrecasas, Miriam
    Munoz, Jenifer
    Alonso-Espinaco, Virginia
    Bujanda, Luis
    Larzabal, Mikel
    Gonzalo, Victoria
    Ocana, Teresa
    Moreira, Leticia
    Goel, Ajay
    Castellvi-Bel, Sergi
    Castells, Antoni
    GASTROENTEROLOGY, 2010, 138 (05) : S150 - S150
  • [23] Novel dominant mutations in Saccharomyces cerevisiae MSH6
    Ruchira Das Gupta
    Richard D. Kolodner
    Nature Genetics, 2000, 24 : 53 - 56
  • [24] Co-occurrence of nonsense mutations in MSH6 and MSH2 in Lynch syndrome families evidencing that not all truncating mutations are equal
    Pinto, Carla
    Pinheiro, Manuela
    Peixoto, Ana
    Santos, Catarina
    Veiga, Isabel
    Rocha, Patricia
    Pinto, Pedro
    Lopes, Paula
    Baptista, Manuela
    Henrique, Rui
    Teixeira, Manuel R.
    JOURNAL OF HUMAN GENETICS, 2016, 61 (02) : 151 - 156
  • [25] Co-occurrence of nonsense mutations in MSH6 and MSH2 in Lynch syndrome families evidencing that not all truncating mutations are equal
    Carla Pinto
    Manuela Pinheiro
    Ana Peixoto
    Catarina Santos
    Isabel Veiga
    Patrícia Rocha
    Pedro Pinto
    Paula Lopes
    Manuela Baptista
    Rui Henrique
    Manuel R Teixeira
    Journal of Human Genetics, 2016, 61 : 151 - 156
  • [26] Compound Heterozygosity for MSH6 Mutations in a Pediatric Lymphoma Patient
    Peters, Antoinette
    Born, Hayley
    Ettinger, Robert
    Levonian, Peter
    Jedele, Kerry Baldwin
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (02) : 113 - 117
  • [27] Incomplete segregation of MSH6 mutations with phenotype of Lynch syndrome
    Duraturo, Francesca
    Liccardo, Raffaella
    Cavallo, Angela
    De Rosa, Marina
    Rossi, Giovanni Battista
    Izzo, Paola
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S66 - S66
  • [28] Functional in silico analysis of missense mutations in the MSH6 gene
    Katarzyna Gajdel
    Grzegorz Kurzawski
    Hereditary Cancer in Clinical Practice, 13 (Suppl 1)
  • [29] A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting
    Ramsoekh, D.
    Wagner, A.
    van Leerdam, M. E.
    Dinjens, W. N. M.
    Steyerberg, E. W.
    Halley, D. J. J.
    Kuipers, E. J.
    Dooijes, D.
    GUT, 2008, 57 (11) : 1539 - 1544
  • [30] Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment
    Laura Belvederesi
    Francesca Bianchi
    Cristian Loretelli
    Raffaella Bracci
    Stefano Cascinu
    Riccardo Cellerino
    Familial Cancer, 2012, 11 : 675 - 680